Clinical Trials Browser

Phase 3 × pembrolizumab × Tumor-Agnostic × Clear all

NCT06901531 2026-03-11

LUCERNA

Phase 3 Recruiting

Adenocarcinoma, Neoplasms

NCT03833167 2026-03-10

KEYNOTE-630

Phase 3 Completed

450 enrolled 18 charts

Carcinoma, Squamous Cell

NCT03976362 2026-02-25

KEYLYNK-008

Phase 3 Completed

851 enrolled 25 charts

Carcinoma

NCT03768063 2026-01-29

IMbrella B

Phase 3 Active not recruiting

Neoplasms